MDXG
MIMEDX GROUP, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.74
−11.58%Price chart
Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21
Key dataOct 21, 2026
Open$4.20
From 52W high−53.02%
Volume2.60M
Market cap$545.79M
P/E (TTM)93.5x
P/S (TTM)1.5x
Div yield—
Key dataOct 21, 2026
Open
$4.20
From 52W high
−53.02%
Volume
2.60M
Market cap
$545.79M
ValuationView details →
P/E (Fwd)
29.3x
EV/EBITDA
17.4x
P/E (TTM)
93.5x
RSI (14)
22.9
MomentumView details →
1D Return
−11.58%
YTD Return
−43.21%
SummaryUpdated Jun 1, 2026
MiMedx Group, Inc. (NASDAQ:MDXG) is a biotechnology company founded in 2008 and headquartered in Marietta, Georgia. The company specializes in developing and distributing placental tissue allografts for various healthcare applications. MiMedx has established itself as a leader in the regenerative medicine space, processing human placental tissues through its proprietary PURION process to create biological products that retain the tissue's natural healing properties. The company has evolved from its early focus on wound care into a diversified portfolio serving surgical recovery, burn treatment, and other medical applications.
Similar companies
Latest newsMore news →
Sanara MedTech Inc. and MIMEDX GROUP, INC.'s deal spread widened after the Federal Trade Commission issued a second request in connection with their deal.5d agoMiMedx Group announced that it will report third-quarter 2026 operating and financial results after the market close on October 28, 2026, followed by a management webcast and conference call at 4:30 p.m. Eastern Time.7d ago